Aldosterone Antagonism in an Inflammatory State: Evidence for Myocardial Protection

Aldosterone Antagonism in an Inflammatory State: Evidence for Myocardial Protection

Introduction. Chagas' disease is one of the most important causes of dilated cardiomyopathy in South and Central America. It is an inflammatory cardiomyopathy. We wanted to investigate whether it could have the same response to aldosterone antagonism as demonstrated before in other dilated card...

Full description

Bibliographic Details
Main Authors:	Felix JA Ramires, Vera MC Salemi, Barbara M Ianni, Fábio Fernandes, Daniel G Martins, Angelina Billate, Edécio Cunha, Charles Mady
Format:	Article
Language:	English
Published:	SAGE Publications 2006-09-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.3317/jraas.2006.026

Similar Items

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
by: Walace de Souza Pimentel, et al.
Published: (2012-09-01)

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
by: Adam K. McDiarmid, et al.
Published: (2020-01-01)

Aldosterone antagonism in heart failure
by: Alan B Miller
Published: (2007-11-01)

Avaliação quantitativa da movimentação parietal regional do ventrículo esquerdo na endomiocardiofibrose Quantitative assessment of left ventricular regional wall motion in endomyocardial fibrosis
by: Charles Mady, et al.
Published: (2005-03-01)

Relação do tamanho do átrio esquerdo com a capacidade de exercício na endomiocardiofibrose Relation between left atrial dimension and exercise capacity in endomyocardial fibrosis
by: Charles Mady, et al.
Published: (2005-03-01)

Ativação adrenérgica intramiocárdica na cardiomiopatia chagásica e doença arterial coronariana Activación adrenérgica intramiocárdica en la cardiomiopatía chagásica y enfermedad arterial coronaria Intramyocardial adrenergic activation in chagasic cardiomyopathy and coronary artery disease
by: Luciano Nastari, et al.
Published: (2011-02-01)

Ativação adrenérgica intramiocárdica na cardiomiopatia chagásica e doença arterial coronariana
by: Luciano Nastari, et al.
Published: (2011-02-01)

Dosagem dos níveis de NT pro-BNP nas afecções pericárdicas e sua utilidade como método complementar de avaliação de restrição diastólica. Experiência inicial de 25 casos: 25 cases
by: Fábio Fernandes, et al.
Published: (2006-03-01)

Aldosterone Antagonism in Atrial Fibrillation: Implications for AF‐Predominant HFpEF
by: Jennifer E. Ho
Published: (2020-09-01)

Review: The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus
by: Justine Davies, et al.
Published: (2002-09-01)

Primary neoplasms of the heart. Clinical and histological presentation of 50 cases
by: Fábio Fernandes, et al.
Published: (2001-03-01)

Níveis séricos de NT pro-BNP: relação com função sistólica e diastólica nas miocardiopatias e pericardiopatias Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies
by: Charles Mady, et al.
Published: (2008-07-01)

Dysregulation of Autonomic Nervous System in Chagas' Heart Disease Is Associated with Altered Adipocytokines Levels.
by: João Marcos Barbosa-Ferreira, et al.
Published: (2015-01-01)

Electrical and myocardial remodeling in primary aldosteronism
by: Mario eCurione, et al.
Published: (2014-11-01)

Doenças cardiovasculares observadas durante o seguimento de um grupo de pacientes na forma indeterminada da doença de Chagas
by: Barbara Maria Ianni, et al.
Published: (1998-07-01)

Valor prognóstico da fração de volume de colágeno na cardiomiopatia hipertrófica Valor pronóstico de la fracción de volumen de colágeno en la cardiomiopatía hipertrófica Prognostic value of the collagen volume fraction in hypertrophic cardiomyopathy
by: Edmundo Arteaga, et al.
Published: (2009-03-01)

Aldosterone and cardiovascular remodelling: focus on myocardial failure
by: Frederick K Shieh, et al.
Published: (2004-03-01)

Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients
by: Renata Cristina Ferreira, et al.
Published: (2003-04-01)

Comprehensive characterization of the effect of mineralocorticoid receptor antagonism with spironolactone on the renin-angiotensin-aldosterone system in healthy dogs.
by: Allison K Masters, et al.
Published: (2024-01-01)

Comprehensive characterization of the effect of mineralocorticoid receptor antagonism with spironolactone on the renin-angiotensin-aldosterone system in healthy dogs
by: Allison K. Masters, et al.
Published: (2024-01-01)

The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
by: Eudy Rena J, et al.
Published: (2011-10-01)

Como era gostoso o meu caldo de cana... The sugarcane juice was delicious, but...
by: Barbara Maria Ianni, et al.
Published: (2005-12-01)

Terapêutica da forma crônica da doença de chagas. É eficaz o tratamento etiológico?
by: Barbara Maria Ianni, et al.
Published: (1998-01-01)

Valor da biópsia de pericárdio no diagnóstico etiológico das pericardiopatias
by: Fábio Fernandes, et al.
Published: (1998-06-01)

The role of air pollution in myocardial remodeling.
by: A M de Oliveira-Fonoff, et al.
Published: (2017-01-01)

Leptin levels in different forms of Chagas' disease
by: F. Fernandes, et al.
Published: (2007-12-01)

Cholesterol pericarditis. A specific but rare cause of pericardial disease
by: Fábio Fernandes, et al.
Published: (2001-05-01)

Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study
by: H. ElSawi, et al.
Published: (2024-02-01)

N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes
by: C. Mady, et al.
Published: (2008-08-01)

Aldosterone exerts anti-inflammatory effects on LPS stimulated microglia
by: Björn-Ole Bast, et al.
Published: (2018-10-01)

Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism
by: Jung Soo Lim, et al.
Published: (2016-12-01)

Afecções Pericárdicas em Pacientes com COVID-19: Uma Possível Causa de Deterioração Hemodinâmica
by: Fábio Fernandes, et al.
Published: (2020-10-01)

SERUM ALDOSTERONE LEVEL DYNAMICS AND CARDIAC REMODELING IN MYOCARDIAL INFARCTION PATIENTS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA TREATED WITH SELECTIVE ALDOSTERONE RECEPTOR BLOCKER
by: E. P. Miroshnichenko, et al.
Published: (2018-09-01)

The efficacy and mechanism of dexmedetomidine in myocardial apoptosis via the renin–angiotensin–aldosterone system
by: Huishu Wang, et al.
Published: (2015-12-01)

Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan
by: Mayyas F, et al.
Published: (2017-09-01)

Effect of aldosterone on collagen formation markers in patients with myocardial infarction and renal dysfunction
by: K .V. Tashchuk, et al.
Published: (2018-07-01)

Molecular and cellular mechanisms of aldosterone producing adenoma development
by: Sheerazed eBoulkroun, et al.
Published: (2015-06-01)

Quilopericárdio idiopático
by: Fernandes Fábio, et al.
Published: (1998-01-01)

Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
by: Giuseppe Maiolino, et al.
Published: (2017-05-01)

Myocardial Aldosterone Receptor and Aquaporin 1 Up-Regulation Is Associated with Cardiomyocyte Remodeling in Human Heart Failure
by: Andrea Frustaci, et al.
Published: (2021-10-01)